Surrogate Endpoints in HTA Decision-Making The need to stay ahead of competitors and offset losses f...
Read moreOptimising evidence generation in trial design, while navigating regulatory and local payer requirem...
Read moreSuccessfully navigating early payer scientific advice whether through Joint Scientific Consultations...
Read moreFive success pillars — your JCA evidence-generation checklist From 12th January 2025, the Eu...
Read moreThe recent Medicines and Healthcare products Regulatory Agency (MHRA) approval of the Alzheimer’s ...
Read moreThe Joint Clinical Assessment (JCA), a core feature of the Regulation (EU) 2021/2282, aims to stream...
Read moreDecisions regarding National Institute for Health and Care Excellence (NICE) appraisals are not made...
Read moreThe National Institute of Health and Care Excellence (NICE) has published several updates and releas...
Read moreMost pharmaceutical products hoping to launch in the UK will be assessed by NICE as a Single Technol...
Read moreSecuring a positive recommendation from the National Institute for Health and Care Excellence (NICE)...
Read more